Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
GILD Coverage
Event
Gilead Sciences, Inc (GILD) Sec Form 10K
Feb 26, 2026
Event
Gilead Sciences, Inc (GILD) Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
Feb 25, 2026
Event
Gilead Sciences, Inc (GILD) Sec Form 8K
Feb 24, 2026
News
S&P 500 Gains as Risk-On Rotation Sends Energy Up 1.84%, Utilities Down 1.68%
Feb 19, 2026
News
Gilead Sciences (GILD) Q4 2025 adj. earnings decline, despite higher revenues
Feb 11, 2026
Transcript
Gilead Sciences, Inc (GILD) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Gilead Sciences, Inc (GILD) Q3 2025 Earnings Call Transcript
Jan 22, 2026
News
Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers
Aug 4, 2023